Genmab — Oktober 2017
-
ingen chance for det JKY
-
Skyldes det dårlige salg ikke os sommerferien, færre klinikdage og orkaner?
-
Man kan kun konstatere at forummet her er for positive. De forsigtige analytikere ligger rigtigt med deres prognoser
-
altså vi kæmpe for at nå den nedre guideline for 2017
-
kæmper
-
Tror i forventer for meget.
-
@sukkeralf, med ingen vækst lander vi på 1134, du har ret
-
Sukkeralf. Selvom vi når den øvre grænse i Genmabs guidance, så lander vi under konsensus estimater
-
817+317
-
Tror helt sikkert vi vil se en kraftig acceleration i salget i Q4. Tænker Q3 aldrig er helt optimalt grundet ferietid, færre klinikdage og så har US været kraftig ramt af orkaner i denne sæson.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind